Bariatric surgery for metabolic unhealthy obesity (MUO) during the COVID era: short-term results of a high-volume center.
COVID-19
Laparoscopic bariatric surgery
Metabolically unhealthy obese
Sleeve gastrectomy
Weight loss
Journal
Eating and weight disorders : EWD
ISSN: 1590-1262
Titre abrégé: Eat Weight Disord
Pays: Germany
ID NLM: 9707113
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
15
11
2021
accepted:
29
06
2022
pubmed:
20
7
2022
medline:
4
1
2023
entrez:
19
7
2022
Statut:
ppublish
Résumé
During the coronavirus disease 19 (COVID-19) outbreak, most public hospitals worldwide have been forced to postpone a major part of bariatric surgery (BS) operations with unfavorable consequences for weight and obesity complications. The aim of this study was to evaluate the effectiveness and safety of laparoscopic BS on subjects with metabolically unhealthy obesity (MUO) during COVID-19 pandemic in a high-volume Italian center. Between March 2020 and January 2021, all patients with MUO submitted to laparoscopic BS (sleeve gastrectomy [SG], one anastomosis gastric bypass [OAGB] and Roux-en-Y gastric bypass [RYGB]) were enrolled according to the ATP III Guidelines, with a minimum follow-up of 3 months. In the study period, 210 patients with MUO underwent laparoscopic BS (77 RYGB, 85 SG and 48 OAGB) in our obesity referral center. Postoperative major complications occurred in 4 patients (1.9%) with zero mortality. At 9-month follow-up, a total weight loss (TWL) of 28.2 ± 18.4, 26.1 ± 23.1 and 24.5 ± 11.3% (p = 0.042) was observed in RYGB, OAGB and SG groups, respectively. The rate of comorbidity resolution was very similar for all type of surgeries (p = 0.871). Only two cases of postoperative SARS-CoV-2 infection were registered (0.9%) and both cases resolved with medical therapy and observation. Among the patients studied, all surgical techniques were safe and effective for MUO during the COVID era. This group of patients is at high risk for general and SARS-CoV-2-related mortality and therefore should be prioritized for BS. Level III, single-center retrospective cohort study.
Identifiants
pubmed: 35852766
doi: 10.1007/s40519-022-01438-y
pii: 10.1007/s40519-022-01438-y
pmc: PMC9294774
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3119-3124Informations de copyright
© 2022. The Author(s).
Références
WHO. Coronavirus (COVID-19) Dashboard. 2022 [cited 2022; Available from: https://covid19.who.int/
; Available from: European Centre for Disease Prevention and Control. ECDC’s weekly COVID-19 surveillance report. Available at: https://www.ecdc.europa.eu/en/covid-19/latest-evidence/epidemiology . Accessed on 28/01/2021
Guglielmi V et al (2021) Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role? Int J Mol Sci 22(6):3183
doi: 10.3390/ijms22063183
Sattar N, McInnes IB, McMurray JJV (2020) Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation 142(1):4–6
doi: 10.1161/CIRCULATIONAHA.120.047659
Richardson S et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 323(20):2052–2059
doi: 10.1001/jama.2020.6775
Barrasa H et al (2020) SARS-CoV-2 in Spanish intensive care units: early experience with 15-day survival in Vitoria. Anaesth Crit Care Pain Med 39(5):553–561
doi: 10.1016/j.accpm.2020.04.001
Drucker DJ (2021) Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metab 33(3):479–498
doi: 10.1016/j.cmet.2021.01.016
Heneghan HM, Nissen S, Schauer PR (2012) Gastrointestinal surgery for obesity and diabetes: weight loss and control of hyperglycemia. Curr Atheroscler Rep 14(6):579–587
doi: 10.1007/s11883-012-0285-5
Perrone F et al (2017) Long-term effects of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass for the treatment of morbid obesity: a monocentric prospective study with minimum follow-up of 5 years. Updates Surg 69(1):101–107
doi: 10.1007/s13304-017-0426-z
Lombardo, (2015) Frequent follow-up visits reduce weight regain in long-term management after bariatric surgery. Bariatric Surg Pract Patient Care 10(3):119–125
doi: 10.1089/bari.2015.0021
Beisani M et al (2021) Effects of COVID-19 lockdown on a bariatric surgery waiting list cohort and its influence in surgical risk perception. Langenbecks Arch Surg 406(2):393–400
doi: 10.1007/s00423-020-02040-5
Albert U et al (2021) Effect of SARS-CoV-2 (COVID-19) Pandemic and lockdown on body weight, maladaptive eating habits, anxiety, and depression in a bariatric surgery waiting list cohort. Obes Surg 31(5):1905–1911
doi: 10.1007/s11695-021-05257-5
Bianciardi E et al (2020) Bariatric surgery closure during COVID-19 lockdown in Italy: the perspective of waiting list candidates. Front Public Health 8:582699
doi: 10.3389/fpubh.2020.582699
Gagliardi AR et al (2021) The psychological burden of waiting for procedures and patient-centred strategies that could support the mental health of wait-listed patients and caregivers during the COVID-19 pandemic: a scoping review. Health Expect 24(3):978–990
doi: 10.1111/hex.13241
Nimeri AA, Matthews BD (2020) Reentry to metabolic and bariatric surgery during the COVID19 pandemic. Obes Surg 30(11):4652–4653
doi: 10.1007/s11695-020-04736-5
Rubino F et al (2020) Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery. Lancet Diabetes Endocrinol 8(7):640–648
doi: 10.1016/S2213-8587(20)30157-1
Angrisani L et al (2020) How are We Going to Restart Elective Bariatric and Metabolic Surgery after the Peak of Covid-19 Pandemic. Sur Res Rep. 3(1):1–5
Aminian A et al (2020) Bariatric surgical practice during the initial phase of COVID-19 outbreak. Obes Surg 30(9):3624–3627
doi: 10.1007/s11695-020-04617-x
Singhal R et al (2021) 30-day morbidity and mortality of bariatric surgery during the COVID-19 pandemic: a multinational cohort study of 7704 patients from 42 countries. Obes Surg 31(10):4272–4288
doi: 10.1007/s11695-021-05493-9
Silecchia G et al (2021) Laparoscopic bariatric surgery is safe during phase 2–3 of COVID-19 pandemic in Italy: a multicenter, prospective, observational study. Diabetes Res Clin Pract 177:108919
doi: 10.1016/j.diabres.2021.108919
Sotgiu G et al (2020) Advanced forecasting of SARS-CoV-2-related deaths in Italy, Germany, Spain, and New York State. Allergy 75(7):1813–1815
doi: 10.1111/all.14327
Third Report of the National Cholesterol Education Program (NCEP) (2002) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106(25):3143–3421
doi: 10.1161/circ.106.25.3143
Meigs JB et al (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91(8):2906–2912
doi: 10.1210/jc.2006-0594
Yumuk V et al (2015) European Guidelines for Obesity Management in Adults. Obes Facts 8(6):402–424
doi: 10.1159/000442721
Francis N et al (2020) SAGES and EAES recommendations for minimally invasive surgery during COVID-19 pandemic. Surg Endosc 34(6):2327–2331
doi: 10.1007/s00464-020-07565-w
Marinari GM et al (2020) Bariatric and metabolic surgery during COVID-19 outbreak phase 2 in Italy: why, when and how to restart. Surg Obes Relat Dis 16(10):1614–1618
doi: 10.1016/j.soard.2020.06.025
Carenzo L et al (2020) Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy. Anaesthesia 75(7):928–934
doi: 10.1111/anae.15072
Ahmed B et al (2021) Serious impacts of postponing bariatric surgery as a result of the COVID-19 pandemic: the patient perspective. J Patient Exp 8:23743735211008280
Naran V et al (2021) The effects of the COVID-19 pandemic on patients with obesity undergoing bariatric care. Surg Obes Relat Dis 17(10):1714–1720
doi: 10.1016/j.soard.2021.05.026
Wolff D et al (2021) Risk factors for Covid-19 severity and fatality: a structured literature review. Infection 49(1):15–28
doi: 10.1007/s15010-020-01509-1
Simonnet A et al (2020) High prevalence of obesity in severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring) 28(7):1195–1199
doi: 10.1002/oby.22831
Kass DA, Duggal P, Cingolani O (2020) Obesity could shift severe COVID-19 disease to younger ages. Lancet 395(10236):1544–1545
doi: 10.1016/S0140-6736(20)31024-2
Smith GI, Mittendorfer B, Klein S (2019) Metabolically healthy obesity: facts and fantasies. J Clin Invest 129(10):3978–3989
doi: 10.1172/JCI129186
Heinberg LJ, Steffen K (2021) Social isolation and loneliness during the COVID-19 pandemic: impact on weight. Curr Obes Rep 10(3):365–370
doi: 10.1007/s13679-021-00447-9
Daigle CR et al (2020) A structured approach for safely reintroducing bariatric surgery in a COVID-19 environment. Obes Surg 30(10):4159–4164
doi: 10.1007/s11695-020-04733-8
Sesti G et al (2011) Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. PLoS ONE 6(3):e17737
doi: 10.1371/journal.pone.0017737
Sjöström L (2013) Review of the key results from the Swedish obese subjects (SOS) trial-a prospective controlled intervention study of bariatric surgery. J Intern Med 273(3):219–234
doi: 10.1111/joim.12012
Goday A et al (2014) Can bariatric surgery improve cardiovascular risk factors in the metabolically healthy but morbidly obese patient? Surg Obes Relat Dis 10(5):871–876
doi: 10.1016/j.soard.2014.04.022
Candi E et al (2018) Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome. Biochem J 475(5):1019–1035
doi: 10.1042/BCJ20170604
Arolfo S et al (2020) COVID-19 outbreak and the practice of surgery: do we need to change? Br J Surg 107(9):e307–e308
doi: 10.1002/bjs.11763
Kang JH, Le QA (2017) Effectiveness of bariatric surgical procedures: a systematic review and network meta-analysis of randomized controlled trials. Medicine (Baltimore) 96(46):e8632
doi: 10.1097/MD.0000000000008632